Under construction – not a live service
Sign in
Not yet recruitingEarly phase 1

Total Osteo-Cartilage Replacement for the Treatment of Osteoarthritis of Knee

Key facts

Phase
Early phase 1

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 45 and 70 years old?

Source: NCT07769632, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
AlSalam Hospital
Trial code
NCT07769632
Record updated
19 August 2026
Original description
Young patients who require total knee arthroplasty with metallic and plastic implants will undergo femoral condyle cartilage and top of the tibia with meniscus replacement. With the proposed surgery patients will have increased range of movements so that they can sit on the ground to fulfill their social was of life, which is not possible with the standard of care total knee replacement.Read full original descriptionShow less

Young patients who require total knee arthroplasty with metallic and plastic implants will undergo femoral condyle cartilage and top of the tibia with meniscus replacement. With the proposed surgery patients will have increased range of movements so that they can sit on the ground to fulfill their social was of life, which is not possible with the standard of care total knee replacement.

Inclusion: Being between 45 and 70 years of age of either gender. (OAK is common in this Age group); Diagnosed with OAK with Kellgren and Lawrence Grading III and IV; No ligamentous laxity and varus or valgus deformity. (In standard TKR patients with ligamentous laxity Constrained Condylar Knee (CCK) with intramedullary stem is used); Patients who wish to have an active lifestyle; Agreeing to participate and signing informed consent voluntarily.

Exclusion: Previous knee surgery within six months; Uncontrolled Diabetes Mellitus; Chronic Kidney Disease. (Patients on hemodialysis); Metabolic bone disease. (Severe osteoporosis with T Score of -<3.5); Mental disorders and drug dependency (Patients who cannot understand the consent or the procedure of the TOCR); Patients who will not consent to follow-up.

ClinicalTrials.gov NCT07769632